Biotechnology; Therapeutics
TreeFrog Therapeutics has raised €71M across 2 funding rounds from 4 investors, most recently a Series B round in Sep 2021. Based in Bordeaux, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2021-09-13 | Series B | €64M | Bpifrance Large Venture,Bristol Myers Squibb,Leonard Green & Partners,XAnge | View deal → |
| 2019-04-01 | Series A | €7.1M | XAnge | View deal → |
